The Soft Tissue Mobilization Techniques on PMS

Status Recruiting

Clinical Trial Summary

The aim of this study is investigate the effects of progressive relaxation and myofascial release technique on blood flow velocity, pain, premenstrual symptoms and quality of life in premenstrual syndrome patients. There are tree groups in the study. These groups are; progressive muscle relaxation group, myofascial relaxation technique and control group. Evaluations will be made by another physical therapist who is blinded to the groups. Participants will be evaluated within the first 3 days of their menstrual cycle. Baseline assessment and post- treatment assessment will be done. Follow-up evaluation will be done on the fifth cycle, two cycles after the post-treatment evaluation.

Clinical Trial Description

The aim of this study is investigate the effects of progressive relaxation and myofascial release technique on blood flow velocity, pain, premenstrual symptoms and quality of life in premenstrual syndrome patients. The study planned as a single-blind randomized controlled trial. The volunteers who were invited to the study and signed the voluntary consent form will be randomized via random allocation software to divided into 3 groups. These groups are; progressive muscle relaxation group, myofascial relaxation technique and control group. Evaluations will be made by another physical therapist who is blinded to the groups. Participants will be evaluated within the first 3 days of their menstrual cycle. Baseline assessment will be done in the first 3 days of the first cycle, after first treatment acute assessment will be done. Post-treatment evaluation will be done in the first 3 days of the 3rd cycle after treatment for two cycles. Follow-up evaluation will be done in the first 3 days of the fifth cycle, two cycles after the post-treatment evaluation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05836454
Study type	Interventional
Source	Eastern Mediterranean University
Contact	Çisel Demiralp, Msc
Phone	05338412953
Email	ptciseldemiralp@gmail.com
Status	Recruiting
Phase	N/A
Start date	September 1, 2022
Completion date	September 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02481973` - The Effect of Individualised Homoeopathic Treatment Using the Grant Bentley Method in Premenstrual Syndrome	Phase 2
Completed	`NCT00195559` - Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder	Phase 3
Completed	`NCT00048854` - Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder	Phase 1/Phase 2
Completed	`NCT00965562` - Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS)	N/A
Completed	`NCT05349344` - Effect of Aerobic Exercise on Premenstrual Syndrome Symptoms (PMS).	N/A
Recruiting	`NCT06146673` - A Multidimensional Study of Premenstrual Syndrome and Body Image
Completed	`NCT05499000` - The Effect of Emotional Freedom Technique on Premenstrual Syndrome	N/A
Recruiting	`NCT06144073` - The Effect of Mandala Art Therapy in Coping With Premenstrual Syndrome	N/A
Recruiting	`NCT06105567` - The Effect of Education Given According to the Health Promotion Model on Premenstrual Symptoms, Emotional Eating Behavior and Perceived Stress	N/A
Completed	`NCT03298607` - The Impact of Serelys PMS on Symptoms of PMS	Phase 3
Recruiting	`NCT06176313` - Effects of Training Given to Cope With Premenstrual Syndrome and Mandala Activity on Premenstrual Symptoms	N/A
Recruiting	`NCT02562053` - Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome?	Phase 3
Completed	`NCT00229346` - Fibromyalgia and Psychiatric Symptoms Among PMS and PMDD Patients	N/A
Completed	`NCT00516113` - A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria	Phase 4
Completed	`NCT04901598` - Physical Activity Level, Aerobic Capacity and Dietary Habits Among a Cohort of Females With Premenstrual Syndrome
Completed	`NCT05692479` - Premenstrual Syndrome and Physical Activity Self-Worth
Not yet recruiting	`NCT06052722` - The Relationship of Premenstrual Syndrome and Primary Dysmenorrhea With Severity of Temporomandibular Disorders	N/A
Completed	`NCT05665972` - Effects of Mandala Coloring on Premenstrual Syndrome	N/A
Completed	`NCT05556252` - The Effect of Hydrogen-rich Water on Premenstrual Symptoms and Quality of Life	N/A
Completed	`NCT05725447` - Cross-cultural Adaptation, Validity and Reliability of the Turkish Version of the Premenstrual Syndrome Impact Questionnaire (PMS-IQ)

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.